LRF Recognizes Family Video President for Another Successful Fundraiser
The Lymphoma Research Foundation has presented Family Video President Keith Hoogland with the 2015 "Hope Award", recognizing the incredible success and continued efforts of the Round It Up for Lymphoma campaign.
In 2015, Hoogland and Family Video raised an impressive $1.3 million for the Lymphoma Research Foundation and for University of Chicago Medicine.
The Round It Up for Lymphoma campaign was launched in 2012, and since then has raised $4.7 million for the Lymphoma Research Foundation’s mission to eradicate lymphoma and for the efforts of the Lymphoma Biobank at the University of Chicago Medicine, which was established by the Hoogland family in 2013.
The Lymphoma Biobank houses vital tissue samples which scientists can use to develop new technology and treatments that will help patients live better and longer.
As has been the case since 2012, this past year between March 13 and 29, customers at Family Video donated to the program by rounding up their rental or sale transactions to the nearest dollar. Contributions from local businesses and grassroots events also added to another year of generous giving. For many employees and customers, these two weeks served as an opportunity to share stories of family and friends impacted by lymphoma.
"We are incredibly grateful to our customers, who have once again shown their generosity for this important cause," said President Keith Hoogland. "Continued support of the Lymphoma Biobank and the Lymphoma Research Foundation will truly make a difference in the fight against this disease – a difference made possible by the people who come into our stores."
“Year after year, Family Video continues to demonstrate an incredible commitment to raising funds and awareness for lymphoma,” added Meghan Gutierrez, Chief Executive Officer of the Lymphoma Research Foundation. “The funds raised by Family Video and their generous patrons support the Lymphoma Research’s Foundation’s mission to eradicate lymphoma and serve those touched by this disease, and promise to bring us one step closer to a cure for this blood cancer.”
Source: PRWeb
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
